Transient receptor potential channels - emerging novel drug targets for the treatment of pain.
about
Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspectiveFrom foe to friend: using animal toxins to investigate ion channel functionAntinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.TRPV4 as a therapeutic target for joint diseases.New strategy for drug discovery by large-scale association analysis of molecular networks of different species.Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trialKunitz-Type Peptide HCRG21 from the Sea Anemone Heteractis crispa Is a Full Antagonist of the TRPV1 Receptor.Furanocoumarins are a novel class of modulators for the transient receptor potential vanilloid type 1 (TRPV1) channel.Calcium-permeable ion channels in pain signaling.New investigational drugs for the treatment of neuropathic pain.Zucapsaicin for the treatment of neuropathic pain.Transient receptor potential ankyrin 1 (TRPA1) antagonists.Skin matters! The role of keratinocytes in nociception: a rational argument for the development of topical analgesicsNovel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one in mice.Blockade of Cannabinoid CB1 Receptors in the Dorsal Periaqueductal Gray Unmasks the Antinociceptive Effect of Local Injections of Anandamide in MiceEvaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain.Evidence and conjecture about mechanisms of cutaneous disease in photodermatology.A Proposed Molecular Mechanism for Physical Analgesia in Chronic Pain.Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrins
P2860
Q26777967-53179211-8343-42D4-ACE1-2AE784B51E67Q26864410-F547D53B-7743-4500-B794-67EA7F081AF6Q35170603-883C577C-ADD4-4961-8FBE-393B4C4D1B67Q35181627-04F4C8EC-DB73-4E09-B3C1-6D866F408BFEQ36615840-EDEF574E-7E2F-43F3-8D8F-37E5F69927C6Q37363551-B8253503-BEBB-479C-9554-E77491B8C93CQ37539438-79A9510F-4935-4AFB-A072-BC7ABDD3C6F8Q37683369-BE0BB8B5-ABDB-4998-8970-865DA3C5D3B6Q38175134-C2853843-AB66-4831-802F-AAB4C11CF94CQ38217614-1D621B1F-8622-4083-A087-0BB7DE0CE634Q38244583-14F63F43-7234-4EAD-91CF-A77EDB0FA1D9Q38411474-EE240A58-D85D-499E-9054-2ED21843CB99Q39061689-82189B6D-5009-4BE5-B438-FCCD15F5C7F5Q41478711-E7810E09-2AA9-4808-8F93-8399933F411EQ41997150-0AFE6C10-8A32-4D65-9E8F-C9945480BF38Q42372994-488E8CEB-BD37-4036-A25C-02B2DB1BC8F8Q44350191-0D2D0FED-F59C-45E9-8CCD-E4E34CA5E490Q51080670-F65CAF1C-1D5D-47A6-9A24-362097442FFAQ55360149-2A8B9566-7F46-4C43-AD85-DAD9A1E87A7DQ58577471-B0509A33-85C0-4447-8D50-5E697F808A4F
P2860
Transient receptor potential channels - emerging novel drug targets for the treatment of pain.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Transient receptor potential c ...... ets for the treatment of pain.
@en
type
label
Transient receptor potential c ...... ets for the treatment of pain.
@en
prefLabel
Transient receptor potential c ...... ets for the treatment of pain.
@en
P2093
P1476
Transient receptor potential c ...... ets for the treatment of pain.
@en
P2093
Andrzej Moniczewski
Kinga Sałat
Tadeusz Librowski
P304
P356
10.2174/09298673113209990107
P577
2013-01-01T00:00:00Z